Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody

BACKGROUND: Identification of predictive biomarkers is essential for the successful development of targeted therapy. Insulin-like growth factor 1 receptor (IGF1R) has been examined as a potential therapeutic target for various cancers. However, recent clinical trials showed that anti-IGF1R antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jun Gyu, Kang, Min Jueng, Yoon, Young-Kwang, Kim, Hwang-Phill, Park, Jinah, Song, Sang-Hyun, Han, Sae-Won, Park, Jong-Wan, Kang, Gyeong Hoon, Kang, Keon Wook, Oh, Do Youn, Im, Seock-Ah, Bang, Yung-Jue, Yi, Eugene C., Kim, Tae-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306383/
https://www.ncbi.nlm.nih.gov/pubmed/22438913
http://dx.doi.org/10.1371/journal.pone.0033322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306383/
https://www.ncbi.nlm.nih.gov/pubmed/22438913
http://dx.doi.org/10.1371/journal.pone.0033322

Ejemplares similares